Iterum Therapeutics PLC reports results for the quarter ended in December - Earnings Summary

Iterum Therapeutics

28/03/2022 14:30

* Iterum Therapeutics PLC  ITRM.OQ  reported a quarterly
adjusted
loss of 2 cents​​ per share for the quarter ended in December.
The lone analyst forecast for the quarter was for a loss of 4
cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Iterum Therapeutics PLC's reported EPS for the quarter was
a
loss of 2 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Iterum Therapeutics PLC shares had risen by 14.3% this
quarter.
    * The company reported a quarterly loss of $4.18 million.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 28 at 01:30 p.m.  ​All
figures in US dollars unless otherwise stated